NPI: 1407256092 · CLEVELAND, OH 44109 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/02/2014
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/02/2014 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,497 | $221K |
| 2019 | 8,184 | $219K |
| 2020 | 4,434 | $188K |
| 2021 | 114 | $7K |
| 2022 | 473 | $24K |
| 2023 | 4,035 | $353K |
| 2024 | 1,659 | $192K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,324 | 1,181 | $1.17M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,987 | 406 | $31K |
| J1756 | Injection, iron sucrose, 1 mg | 1,185 | 246 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,100 | 249 | $1K |
| 85041 | 40 | 36 | $0.00 | |
| 82108 | 13 | 12 | $0.00 | |
| 83540 | 13 | 12 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 135 | 48 | $0.00 |
| 85048 | 40 | 36 | $0.00 | |
| 83970 | 13 | 12 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 2,507 | 489 | $0.00 |
| 82728 | 26 | 24 | $0.00 | |
| 83550 | 13 | 12 | $0.00 |